Fluorescence Cystoscopy with High-Resolution Optical Coherence Tomography Imaging as an Adjunct Reduces False-Positive Findings in the Diagnosis of Urothelial Carcinoma of the Bladder

European Urology

Volumn 56, Issue 6, 2009, Pages 914-919

  Schmidbauer, Joerg ^a   Remzi, Mesut ^a   Klatte, Tobias ^a   Waldert, Matthias ^a   Mauermann, Julian ^a   Susani, Martin ^a   Marberger, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bladder cancer; Fluorescence; Hexaminolevulinate; Optical coherence tomography; Photodynamic diagnosis

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER UROTHELIAL CARCINOMA; BLUE LIGHT; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG INSTILLATION; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE CYSTOSCOPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME; TUMOR BIOPSY; UROTHELIUM; WHITE LIGHT;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CYSTOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 70350564784     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.07.042     Document Type: Article

References (20)

1. D'Hallewin M.-A., Bezdetnaya L., and Guillemin F. Fluorescence detection of bladder cancer: a review. Eur Urol 42 (2002) 417-425
2. Hungerhuber E., Stepp H., Kriegmair M., et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69 (2007) 260-264
3. Filbeck T., Pichlmeier U., Knuechel R., Wieland W.F., and Roessler W. Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma?. Urology 60 (2002) 1025-1028
4. Schmidbauer J., Witjes F., Schmeller N., Donat R., Susani M., and Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 171 (2004) 135-138
5. Jichlinski P., Guillou L., Karlsen S.J., et al. Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 170 (2003) 226-229
6. Jocham D., Witjes F., Wagner S., et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174 (2005) 862-866
7. Joudi F.N., and Konetny B.R. Fluorescence cystoscopy and bladder surveillance. Curr Opin Urol 14 (2004) 265-270
8. Grimbergen M.C.M., van Swol C.F.P., Jonges T.G.N., Boon T.A., and van Moorselaar R.J.A. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 44 (2003) 51-56
9. Spiess P.E., and Grossman H.B. Fluorescence cystoscopy: is it ready for use in routine clinical practice?. Curr Opin Urol 16 (2006) 372-376
10. Jocham D., Stepp H., and Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 53 (2008) 1138-1150
11. Lerner S.P., Goh A.C., Tresser N.J., and Shen S.S. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 72 (2008) 133-137
12. In: Sobin L.H., and Wittekind C.H. (Eds). TNM classification of malignant tumours. 6th ed. (2002), Weinheim/Wiley-Liss, New York, NY
13. Epstein J.I., Amin M.B., Reuter V.R., and Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435-1448
14. Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A.E. Pathology and genetics of tumours of the urinary system and male genital organs. WHO Classification of Tumours Vol 7 (2004), IARC Press, Lyon, France pp. 89-158
15. Lopez-Beltran A., and Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46 (2004) 170-176
16. Jaeschke R., Guyott G., and Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?. JAMA 271 (1994) 703-707
17. Witjes J.A., and Douglass J. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Nat Clin Pract Urol 4 (2007) 542-549
18. Fradet Y., Grossman H.B., Gomella L., et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 178 (2007) 68-73
19. Grossman H.B., Gomella L., Fradet Y., et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 178 (2007) 62-67
20. Jichlinski P., and Jacqmin D. Photodynamic diagnosis in non-muscle-invasive bladder cancer. Eur Urol Suppl 7 (2008) 529-535